The effect of mobile phone utilization for enhanced adherence counselling intervention among persons with HIV

References

• Abdulrahman, S. A., Rampal, L., Ibrahim, F., Radhakrishnan, A. P., Kadir Shahar, H., & Othman, N. (2017). Mobile phone reminders and peer counseling improve adherence and treatment outcomes of patients on ART in Malaysia: A randomized clinical trial. PloS One, 12(5), e0177698. https://doi.org/10.1371/journal.pone.0177698
   PubMed Web of Science ®Google Scholar
• Al-Dakkak, I., Patel, S., McCann, E., Gadkari, A., Prajapati, G., & Maiese, E. M. (2013). The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematic review and meta-analysis. AIDS Care, 25(4), 400–414. https://doi.org/10.1080/09540121.2012.712667
   PubMed Web of Science ®Google Scholar
• Atnafu, G. T., Moges, N. A., Wubie, M., & Gedif, G. (2022). Incidence and predictors of viral load suppression after enhanced adherence counseling among HIV-positive adults in West Gojjam Zone, Amhara Region, Ethiopia. Infection and Drug Resistance, 15, 261–274. https://doi.org/10.2147/IDR.S341392
   PubMed Web of Science ®Google Scholar
• Azia, I., Mukumbang, F., & Van Wyk, B. (2016). Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South Africa. Southern African Journal of HIV Medicine, 17(1), https://doi.org/10.4102/hivmed.v17i1.476
   PubMed Web of Science ®Google Scholar
• Boateng, D., Kwapong, G. D., & Agyei-Baffour, P. (2013). Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child-transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: A cross-sectional study. BMC Women’s Health, 13(2), https://doi.org/10.1186/1472-6874-13-2
   PubMedGoogle Scholar
• Bvochora, T., Satyanarayana, S., Takarinda, K. C., Bara, H., Chonzi, P., Komtenza, B., Duri, C., & Apollo, T. (2019). Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues. PLOS ONE, 14(2), e0211326. https://doi.org/10.1371/journal.pone.0211326
   PubMed Web of Science ®Google Scholar
• Byrd, K. K., Hou, J. G., Hazen, R., Kirkham, H., Suzuki, S., Clay, P. G., Bush, T., Camp, N. M., Weidle, P. J., & Delpino, A. (2019). Antiretroviral adherence level necessary for HIV viral suppression using real-world data. Journal of Acquired Immune Deficiency Syndromes (1999), 82(3), 245–251. https://doi.org/10.1097/QAI.0000000000002142
   PubMed Web of Science ®Google Scholar
• Dagli-Hernandez, C., Lucchetta, R. C., de Nadai, T. R., Galduróz, J. C. F., & Mastroianni, P. de C. (2016). Self-perception of knowledge and adherence reflecting the effectiveness of antiretroviral therapy. Patient Preference and Adherence, 10, 1787–1793. https://doi.org/10.2147/PPA.S112108
   PubMed Web of Science ®Google Scholar
• Diress, G., Dagne, S., Alemnew, B., Adane, S., & Addisu, A. (2020). Viral load suppression after enhanced adherence counseling and Its predictors among high viral load HIV seropositive people in north Wollo zone public hospitals, northeast Ethiopia, 2019: Retrospective cohort study. AIDS Research and Treatment, 2020, 8909232. https://doi.org/10.1155/2020/8909232
   PubMed Web of Science ®Google Scholar
• Finitsis, D. J., Pellowski, J. A., & Johnson, B. T. (2014). Text message intervention designs to promote adherence to antiretroviral therapy (ART): A meta-analysis of randomized controlled trials. PloS One, 9(2), e88166. https://doi.org/10.1371/journal.pone.0088166
   PubMed Web of Science ®Google Scholar
• Ford, N., Flexner, C., Vella, S., Ripin, D., & Vitoria, M. (2013). Optimization and simplification of antiretroviral therapy for adults and children. Current Opinion in HIV and AIDS, 8(6), 591–599. https://doi.org/10.1097/COH.0000000000000010
   PubMed Web of Science ®Google Scholar
• Gregson, J., Tang, M., Ndembi, N., Hamers, R. L., Rhee, S.-Y., Marconi, V. C., Diero, L., Brooks, K. A., Theys, K., de Wit, T. R., Arruda, M., Garcia, F., Monge, S., Günthard, H. F., Hoffmann, C. J., Kanki, P. J., Kumarasamy, N., Kerschberger, B., Mor, O., … Gupta, R. K. (2016). Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study. The Lancet Infectious Diseases, 16(5), 565–575. https://doi.org/10.1016/S1473-3099(15)00536-8
   PubMed Web of Science ®Google Scholar
• Harrigan, P. Richard, Hogg, Robert S, Dong, Winnie W. Y, Yip, Benita, Wynhoven, Brian, Woodward, Justin, Brumme, Chanson J., Brumme, Zabrina L, Mo, Theresa, Alexander, Chris S., & Montaner, Julio S. G. (2005). Predictors of HIV drug‐resistance mutations in a large antiretroviral‐naive cohort initiating triple antiretroviral therapy. The Journal of Infectious Diseases, 191(3), 339–347. http://doi.org/10.1086/jid.2005.191.issue-3
   PubMed Web of Science ®Google Scholar
• Huang, D., Sangthong, R., McNeil, E., Chongsuvivatwong, V., Zheng, W., & Yang, X. (2013). Effects of a phone call intervention to promote adherence to antiretroviral therapy and quality of life of HIV/AIDS patients in Baoshan, China: A randomized controlled trial. AIDS Research and Treatment, 2013, 580974. https://doi.org/10.1155/2013/580974
   PubMedGoogle Scholar
• Inzaule, S. C., Hamers, R. L., Doherty, M., Shafer, R. W., Bertagnolio, S., de Wit, R., & F, T. (2019). Curbing the rise of HIV drug resistance in low-income and middle-income countries: The role of dolutegravir-containing regimens. The Lancet. Infectious Diseases, 19(7), e246–e252. https://doi.org/10.1016/S1473-3099(18)30710-2
   PubMed Web of Science ®Google Scholar
• Jordan, M. R., Hamunime, N., Bikinesi, L., Sawadogo, S., Agolory, S., Shiningavamwe, A. N., Negussie, T., Fisher-Walker, C. L., Raizes, E. G., Mutenda, N., Hunter, C. J., Dean, N., Steegen, K., Kana, V., Carmona, S., Yang, C., Tang, A. M., Parkin, N., & Hong, S. Y. (2020). High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia. Medicine, 99(37), e21661. https://doi.org/10.1097/MD.0000000000021661
   PubMed Web of Science ®Google Scholar
• Kouamou, V., Varyani, B., Shamu, T., Mapangisana, T., Chimbetete, C., Mudzviti, T., Manasa, J., & Katzenstein, D. (2020). Drug resistance among adolescents and young adults with virologic failure of first-line antiretroviral therapy and response to second-line treatment. AIDS Research and Human Retroviruses, 36(7), 566–573. https://doi.org/10.1089/AID.2019.0232
   PubMed Web of Science ®Google Scholar
• NAMSAL ANRS 12313 Study Group, Kouanfack, C., Mpoudi-Etame, M., Omgba Bassega, P., Eymard-Duvernay, S., Leroy, S., Boyer, S., Peeters, M., Calmy, A., & Delaporte, E. (2019). Dolutegravir-based or low-dose Efavirenz-based regimen for the treatment of HIV-1. The New England Journal of Medicine, 381(9), 816–826. https://doi.org/10.1056/NEJMoa1904340
   PubMed Web of Science ®Google Scholar
• Laxmeshwar, C., Acharya, S., Das, M., Keskar, P., Pazare, A., Ingole, N., Mehta, P., Gori, P., Mansoor, H., Kalon, S., Singh, P., Mathur, T., Ferlazzo, G., & Isaakidis, P. (2020). Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India. PLOS ONE, 15(5), e0232576. https://doi.org/10.1371/journal.pone.0232576
   PubMed Web of Science ®Google Scholar
• Mitchell, K. J., Bull, S., Kiwanuka, J., & Ybarra, M. L. (2011). Cell phone usage among adolescents in Uganda: Acceptability for relaying health information. Health Education Research, 26(5), 770–781. https://doi.org/10.1093/her/cyr022
   PubMed Web of Science ®Google Scholar
• Nachega, J. B., Parienti, J.-J., Uthman, O. A., Gross, R., Dowdy, D. W., Sax, P. E., Gallant, J. E., Mugavero, M. J., Mills, E. J., & Giordano, T. P. (2014). Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 58(9), 1297–1307. https://doi.org/10.1093/cid/ciu0460
   PubMed Web of Science ®Google Scholar
• Nasuuna, E., Kigozi, J., Babirye, L., Muganzi, A., Sewankambo, N. K., & Nakanjako, D. (2018). Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. BMC Public Health, 18(1), 1048. https://doi.org/10.1186/s12889-018-5964-x
   PubMed Web of Science ®Google Scholar
• Nguyen, P. M., Thach, A. N., Pham, X. D., Lam, A. N., Nguyen, T. N. P., Duong, C. X., Nguyen, L. V., Nguyen, T. H., Pham, S. T., Taxis, K., & Nguyen, T. (2021). Prevalence and determinants of medication adherence among patients with HIV/AIDS in Southern Vietnam. Infectious Disease Reports, 13(1), 126–135. https://doi.org/10.3390/idr13010014
   PubMed Web of Science ®Google Scholar
• Pop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., Zivin, J. G., Goldstein, M. P., de Walque, D., MacKeen, L., Haberer, J., Kimaiyo, S., Sidle, J., Ngare, D., & Bangsberg, D. R. (2011). Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: A randomized controlled trial of text message reminders. AIDS (London, England), 25(6), 825–834. https://doi.org/10.1097/QAD.0b013e32834380c1
   PubMed Web of Science ®Google Scholar
• Shubber, Z., Mills, E. J., Nachega, J. B., Vreeman, R., Freitas, M., Bock, P., Nsanzimana, S., Penazzato, M., Appolo, T., Doherty, M., & Ford, N. (2016). Patient-reported barriers to adherence to antiretroviral therapy: A systematic review and meta-analysis. PLoS Medicine, 13(11), e1002183. https://doi.org/10.1371/journal.pmed.1002183
   PubMed Web of Science ®Google Scholar
• WHO. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach (2nd ed.). World Health Organization. https://www.who.int/publications/i/item/9789241549684.
   Google Scholar
• WHO. (2019). Update of recommendations on first- and second-line antiretroviral regimens. https://www.who.int/publications-detail-redirect/WHO-CDS-HIV-19.15
   Google Scholar
• WHO. (2021). Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: Recommendations for a public health approach. https://www.who.int/publications-detail-redirect/9789240031593
   Google Scholar
• WHO-HIV-2017.13-eng.pdf. (n.d.). Retrieved September 30, 2022, from http://apps.who.int/iris/bitstream/handle/10665/255867/WHO-HIV-2017.13-eng.pdf?sequence=1
   Google Scholar
• World Health Organization, Centers for Disease Control and Prevention (U.S.), United States. Agency for International Development, Global Fund to Fight AIDS, T. and M., & African Society for Laboratory Medicine. (2014). Technical and operational considerations for implementing HIV viral load testing: Interim technical update. World Health Organization. https://apps.who.int/iris/handle/10665/128121
   Google Scholar